Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Doumas

Showing results (31-40 of 380) with videos related to

Pageof 38
Sort By:
Hypertension (Dallas, Tex. : 1979)|August 14, 2013
Masked hypertension in untreated and treated patients with diabetes mellitus: attractive but questionable interpretationsMichael Doumas, Antonios Lazaridis, Andromachi Reklou
Journal of Hypertension|October 11, 2013
Effects of hypertension and antihypertensive therapy on sexual function in the elderly: the jury is still outMichael Doumas, Antonios Lazaridis, Andromachi Reklou
British Journal of Clinical Pharmacology|May 16, 2022
Serum uric acid lowering mediated by glucagon-like peptide-1 receptor agonists: Emerging considerationsDimitrios Patoulias, Christodoulos Papadopoulos, Michael Doumas
International Journal of Cardiology|August 19, 2020
Sodium-glucose co-transporter-2 inhibitor and glucagon-like peptide-1 receptor agonist combination treatment: Promising, but shall we look at other indices?Dimitrios Patoulias, Christodoulos Papadopoulos, Michael Doumas
Acta Diabetologica|January 28, 2020
Pericardial fat in type 2 diabetes: not just a biomarker, but a promising treatment target?Dimitrios Patoulias, Christodoulos Papadopoulos, Michael Doumas
JAMA Internal Medicine|March 9, 2016
Discontinuation of Antihypertensive Treatment in Elderly Patients and Cognitive FunctionKonstantinos Imprialos, Chrysoula Boutari, Michael Doumas
American Heart Journal|April 27, 2021
Sodium-glucose co-transporter-2 inhibitors and sacubitril/valsartan combination in patients with heart failure with reduced ejection fraction; does it deserve our attention?Dimitrios Patoulias, Christodoulos Papadopoulos, Michael Doumas
Expert Opinion on Therapeutic Targets|April 2, 2009
Carotid baroreceptor stimulation as a therapeutic target in hypertension and other cardiovascular conditionsMichael Doumas, Daqing Guo, Vasilios Papademetriou
Archives of Internal Medicine|April 12, 2012
Management of erectile dysfunction: do not forget hypertensionMichael Doumas, Panagiota Anyfanti, Areti Triantafyllou
Journal of Hypertension|April 13, 2012
Should ambulatory blood pressure monitoring be mandatory for future studies in resistant hypertension: a perspectiveMichael Doumas, Panagiota Anyfanti, George Bakris
Pageof 38

Showing results (31-40 of 380) with videos related to

Sort By:
Pageof 38
Hypertension (Dallas, Tex. : 1979)|August 14, 2013
Masked hypertension in untreated and treated patients with diabetes mellitus: attractive but questionable interpretationsMichael Doumas, Antonios Lazaridis, Andromachi Reklou
Journal of Hypertension|October 11, 2013
Effects of hypertension and antihypertensive therapy on sexual function in the elderly: the jury is still outMichael Doumas, Antonios Lazaridis, Andromachi Reklou
British Journal of Clinical Pharmacology|May 16, 2022
Serum uric acid lowering mediated by glucagon-like peptide-1 receptor agonists: Emerging considerationsDimitrios Patoulias, Christodoulos Papadopoulos, Michael Doumas
International Journal of Cardiology|August 19, 2020
Sodium-glucose co-transporter-2 inhibitor and glucagon-like peptide-1 receptor agonist combination treatment: Promising, but shall we look at other indices?Dimitrios Patoulias, Christodoulos Papadopoulos, Michael Doumas
Acta Diabetologica|January 28, 2020
Pericardial fat in type 2 diabetes: not just a biomarker, but a promising treatment target?Dimitrios Patoulias, Christodoulos Papadopoulos, Michael Doumas
JAMA Internal Medicine|March 9, 2016
Discontinuation of Antihypertensive Treatment in Elderly Patients and Cognitive FunctionKonstantinos Imprialos, Chrysoula Boutari, Michael Doumas
American Heart Journal|April 27, 2021
Sodium-glucose co-transporter-2 inhibitors and sacubitril/valsartan combination in patients with heart failure with reduced ejection fraction; does it deserve our attention?Dimitrios Patoulias, Christodoulos Papadopoulos, Michael Doumas
Expert Opinion on Therapeutic Targets|April 2, 2009
Carotid baroreceptor stimulation as a therapeutic target in hypertension and other cardiovascular conditionsMichael Doumas, Daqing Guo, Vasilios Papademetriou
Archives of Internal Medicine|April 12, 2012
Management of erectile dysfunction: do not forget hypertensionMichael Doumas, Panagiota Anyfanti, Areti Triantafyllou
Journal of Hypertension|April 13, 2012
Should ambulatory blood pressure monitoring be mandatory for future studies in resistant hypertension: a perspectiveMichael Doumas, Panagiota Anyfanti, George Bakris
Pageof 38